# US 2024/0423616 A1 · Compressible surgical adjuncts, cartridges, and cartridge assemblies

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0423616 A1
- Document ID: US20240423616A1
- Status: Published application
- Kind: A1
- Application number: 18/484,807
- Filed: 2023-10-11
- Published: 2024-12-26
- Earliest claimed: 2023-06-22
- Assignees: Cilag GmbH International
- Applicants: Cilag GmbH International
- Inventors: PEYTON HOPSON; MADELAINE FRANZONI; CHRISTOPHER Q. SEOW; MICHAEL J. VENDELY; JASON L. HARRIS
- Web page: https://patentgrep.com/patent/US20240423616A1

## CPC

- A61B 17/0644: {penetrating the tissue, deformable to closed position}
- A61B 17/068: Surgical staplers {, e.g. containing multiple staples or clamps}({staplers containing only one staple A61B17/10; magazines or containers for staples A61B17/105;} for performing anastomosis A61B17/115; {staplers in general B25C5/00})
- A61B 17/07207: {the staples being applied sequentially}
- A61B 17/07292: {Reinforcements for staple line, e.g. pledgets}
- A61L 17/005: {containing a biologically active substance, e.g. a medicament or a biocide}
- A61L 17/10: containing macromolecular materials
- A61L 17/145: {Coating}
- A61L 24/0042: {Materials resorbable by the body}
- A61L 27/18: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/28: Materials for coating prostheses
- A61L 27/50: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 27/52: Hydrogels or hydrocolloids
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 27/56: Porous materials, {e.g. foams or sponges}
- A61L 27/58: Materials at least partially resorbable by the body
- A61L 31/041: {Mixtures of macromolecular compounds}
- A61L 31/06: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)}
- A61L 31/10: Macromolecular materials
- A61L 31/128: {containing other specific inorganic fillers not covered by A61L31/126 or A61L31/127}
- A61L 31/129: {containing macromolecular fillers}
- A61L 31/146: {Porous materials, e.g. foams or sponges}
- A61L 31/148: {Materials at least partially resorbable by the body}
- A61L 31/16: Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)}
- B29C 65/4855: {characterised by their physical properties, e.g. being electrically-conductive}
- B29C 65/4885: {characterised by their composition being non-plastics}
- B29C 65/52: {characterised by the way of} applying the adhesive {(B29C65/50 takes precedence; apparatus for applying liquids in general B05C; processes for applying liquids in general B05D)}
- C08G 18/4277: {Caprolactone and/or substituted caprolactone}
- C08G 18/428: {Lactides}
- C08G 18/4283: {Hydroxycarboxylic acid or ester}
- C08L 75/04: Polyurethanes
- A61B 2017/00004: {(bio)absorbable, (bio)resorbable or resorptive}
- A61B 2017/00526: {Methods of manufacturing}
- A61B 2017/00867: {shape memory effect}
- A61B 2017/00871: {polymeric}
- A61B 2017/00889: {antimicrobial, disinfectant}
- A61B 2017/00893: {pharmaceutically effective}
- A61B 2017/00938: {hydrophobic}
- A61B 2017/00951: {adhesive}
- A61B 2017/00964: {composite}
- A61B 2017/07271: {characterised by its cartridge}
- A61B 2017/07278: {characterised by its sled or its staple holder}
- A61L 2300/404: Biocides, antimicrobial agents, antiseptic agents
- A61L 2300/604: Biodegradation
- A61L 2400/12: Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
- A61L 2400/16: Materials with shape-memory or superelastic properties
- A61L 2420/02: Methods for coating medical devices
- B29K 2075/00: Use of {PU, i.e.} polyureas or polyurethanes {or derivatives thereof}, as moulding material
- B29K 2105/04: cellular or porous
- B29L 2031/7546: {Surgical equipment}
- C08G 18/14: {Manufacture of cellular products}
- C08G 2230/00: Compositions for preparing biodegradable polymers
- C08L 2203/02: for biomedical use
- C08L 2312/00: Crosslinking
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- B29C: SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING (making preforms B29B11/00; making laminated products by combining previously unconnected layers which become one product whose layers will remain together B32B37/00 - B32B41/00)
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)
- B29K: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR {MOULDS, } REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29L: INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES

## Abstract

The disclosed technology includes a surgical adjunct that includes a polyurethane foam. A volumetric ratio of the polyurethane foam to the total volume of the surgical adjunct may be in a range of about 0.125 to about 0.325. A glass transition temperature of the surgical adjunct may be about 0° C. to about 40° C.

## Claims

### Claim at position 1

1-15. (canceled)

### Claim 16

A surgical adjunct, comprising:
a polyurethane foam comprising a volumetric ratio of the polyurethane foam to the total volume of the surgical adjunct is in a range of about 0.125 to about 0.325,
wherein a glass transition temperature of the surgical adjunct is about 0° C. to about 40° C.

### Claim 17 (depends on 16)

The surgical adjunct of claim 16, wherein the volumetric ratio of the polyurethane foam to total volume of the surgical adjunct is about 0.175 to about 0.225.

### Claim 18 (depends on 16)

The surgical adjunct of claim 16, wherein the volumetric ratio of the polyurethane foam to total volume of the surgical adjunct is about 0.19 to about 0.21

### Claim 19 (depends on 16)

The surgical adjunct of claim 16, wherein the glass transition temperature of the surgical adjunct is about 7.5° C. to about 22.5° C.

### Claim 20 (depends on 16)

The surgical adjunct of claim 16, wherein the glass transition temperature of the surgical adjunct is about 12.5° C. to about 17.5° C.

### Claim 21 (depends on 16)

The surgical adjunct of claim 16, wherein a median pore size of the surgical adjunct is about 0.025 to about 0.300 mm3.

### Claim 22 (depends on 16)

The surgical adjunct of claim 16, further comprising a polydioxanone (PDO) film disposed on at least one surface of the polyurethane foam.

### Claim 23 (depends on 22)

The surgical adjunct of claim 22, wherein the PDO film has a thickness of about 20 μm to about 100 μm.

### Claim 24 (depends on 16)

The surgical adjunct of claim 16, further comprising a plasticizer added to the polyurethane foam.

### Claim 25 (depends on 24)

The surgical adjunct of claim 24, wherein the plasticizer comprises at least one of a low molecular weight glycol, polyethylene glycol, polyvinylpyrrolidone, dibutyl sebacate, glyceryl triacetate, glyceryl behenate, hexanoic acid, decanoic acid, octadecanoic acid, boric ester, and a fatty acid.

### Claim 26 (depends on 24)

The surgical adjunct of claim 24, wherein the plasticizer comprises at least one fatty acid.

### Claim 27 (depends on 16)

The surgical adjunct of claim 16, wherein the surgical adjunct has a compression strength of about 30 kPa to about 70 kPa.

### Claim 28 (depends on 27)

The surgical adjunct of claim 27, wherein the compression strength is about 30 to about 60 kPa.

### Claim 29 (depends on 16)

The surgical adjunct of claim 16, wherein the surgical adjunct has a peak tensile strength of about 50 to about 150 kPa.

### Claim 30 (depends on 16)

The surgical adjunct of claim 16, wherein the surgical adjunct has: a length of about 40 mm to about 80 mm; a width of about 8 mm to about 12 mm; and a height of about 2.5 mm to about 3.5 mm.

### Claim 31 (depends on 30)

The surgical adjunct of claim 30, wherein the surgical adjunct has a distal end chamfer and a proximal end chamfer,
wherein the distal end chamfer comprises a vertical portion extending from a bottom of the surgical adjunct, the vertical portion has a height of about 0.009 inches to about 0.029 inches,
wherein the distal end chamfer comprises an angled portion extending from the vertical portion to a top surface a of the surgical adjunct, the angled portion has a slope of about 30 degrees to about 60 degrees in reference to the top surface,
wherein the proximal end chamfer comprises a proximal end with a width of about 0.27 inches to about 0.29 inches, and
wherein the proximal end chamfer comprises a first angled side extension and a second angled side extension extending away from the distal end of the surgical adjunct to the proximal end of proximal end chamfer, the first angled side extension and the second angled side extensions each have lengths of about 0.01 inches to about 0.40 inches when measured horizontally.

### Claim 32 (depends on 1)

The surgical adjunct of claim 1, further comprising a plurality of struts having a median strut thickness of about 0.025 mm to about 0.300 mm.

### Claim 33

A method of making a surgical adjunct, comprising:
selectively adding a plasticizer to a polyurethane foam to generate the surgical adjunct,
wherein the surgical adjunct has a glass transition temperature of about 0° C. to about 40° C.

### Claim 34 (depends on 33)

The method of claim 33, wherein selectively adding the plasticizer comprises either soaking the polyurethane foam in in a solution comprising the plasticizer or adding the plasticizer on at least a portion of at least one surface of the polyurethane foam via direct deposition, and
wherein a volumetric ratio of the polyurethane foam to the total volume of the surgical adjunct is in a range of about 0.125 to about 0.325.

### Claim 35 (depends on 33)

The method of claim 33, further comprising:
laminating the polyurethane foam with a polydioxanone (PDO) film by:
adhering one side of the polyurethane foam with a PDO film to create a partially sealed foam;
subjecting the partially sealed foam to a temperature of about 105° C. to about 115° C.;
subjecting the partially sealed foam to a pressure of about 5 kN;
letting the partially sealed foam stand at least thirty seconds; and
subjecting the partially sealed foam to a temperature of about 35° C. to about 45° C.
